Latest Insider Transactions at Allena Pharmaceuticals, Inc. (ALNA)
This section provides a real-time view of insider transactions for Allena Pharmaceuticals, Inc. (ALNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Allena Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Allena Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2021
|
Louis Md Brenner President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
125,582
+27.63%
|
-
|
|
Nov 15
2021
|
Louis Md Brenner President and CEO |
SELL
Open market or private sale
|
Direct |
40,328
-12.26%
|
$0
$0.81 P/Share
|
|
May 10
2021
|
Louis Md Brenner President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
83,721
+26.81%
|
-
|
|
May 10
2021
|
Louis Md Brenner President and CEO |
SELL
Open market or private sale
|
Direct |
25,215
-11.03%
|
$25,215
$1.11 P/Share
|
|
Dec 17
2020
|
Louis Md Brenner President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
247,932
+50.0%
|
-
|
|
Dec 17
2020
|
Louis Md Brenner President and CEO |
SELL
Open market or private sale
|
Direct |
103,116
-41.59%
|
$103,116
$1.36 P/Share
|
|
Dec 17
2020
|
Edward Wholihan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
164,822
+46.48%
|
-
|
|
Dec 17
2020
|
Edward Wholihan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
68,550
-36.11%
|
$68,550
$1.36 P/Share
|
|
Nov 06
2017
|
Third Rock Ventures Ii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
215,000
+7.15%
|
$3,010,000
$14.0 P/Share
|
|
Nov 06
2017
|
Third Rock Ventures Ii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,575,964
+50.0%
|
-
|